SNY:NASDAQ
Sanofi SA
39,12 US$
0,00%
(0,00) 1D
39,37 US$
arrow_upward
+0,64% (+0,25)todayPara orarit të tregut
Mbyllur: 13 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SNY...
Kapitalizimi i tregut
95,35 mld
Vëllimi mesatar
2,87 mln
Vëllimi
62,48 mijë
Dividendi
6,18%
Dividendi tremujor
0,60 US$
Data e ndërprerjes së dividendit
5 maj 2026
Raporti çmim/fitim
21,43
Maksimumi 52-javor
52,68 US$
Minimumi 52-javor
39,07 US$
Fitimet për aksion
1,83 US$
Beta
0,37
Aksionet në qarkullim
2,42 mld
Numri i punonjësve
75 mijë
Kapitalizimi i tregut
95,35 mld
Vëllimi mesatar
2,87 mln
Vëllimi
62,48 mijë
Dividendi
6,18%
Dividendi tremujor
0,60 US$
Data e ndërprerjes së dividendit
5 maj 2026
Raporti çmim/fitim
21,43
Maksimumi 52-javor
52,68 US$
Minimumi 52-javor
39,07 US$
Fitimet për aksion
1,83 US$
Beta
0,37
Aksionet në qarkullim
2,42 mld
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
55 minuta më parë
Sanofi set October 30 results date as Sanofi stock trades at EUR 70.80
Euronext Markets: Real-time Stock Market Data | live
·
4 orë më parë
Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
News Corp
·
21 orë më parë
Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.
ad-hoc-news.de
·
1 ditë më parë
Sanofi expanded Regeneron alliance: Sanofi stock gains 1.34 percent
Profili
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Rreth Sanofi SA
Drejtori ekzekutivBelén Garijo | Paul Hudson
Punonjësit74,8 mijë
Themeluar më1973
SeliaParisi, Île-de-France, Francë
Sektori-
Uebsajtisanofi.com